Insights & Updates

Blog thumbnail

Hydropower's ESG Paradox: Why the "Green" Asset Class Tops the Controversy Charts

August 20, 2026
5 mins read
Hydropower tops ESG controversy volume across 250,000+ projects, outranking coal. Why the greenest label in energy hides the heaviest social risk.

An analysis of over 250,000 infrastructure projects reveals that the sector most often filed under "clean energy" carries the heaviest environmental and social controversy footprint of any asset type assessed.

In the taxonomy of energy infrastructure, hydropower occupies a comfortable position. It is renewable, dispatchable, and long-lived, and it enters transition frameworks, green bond eligibility criteria, and net-zero roadmaps with minimal friction. Where coal is a legacy liability to be managed down and nuclear invites a specialized debate, hydropower is largely treated as settled. What these projects have actually done does not support that treatment.

Belo Monte, an 11,233 MW complex on the Xingu River in Pará, Brazil, is the sharpest test of the point, because it was built to answer this exact objection. Approved after decades of opposition to a far larger design, it was engineered as a run-of-river plant to minimize flooding, and its reservoirs cover 478 km², of which 274 km² was already river channel at high water, a 61% reduction compared with the 1980s proposal, according to the operator's own regulatory filing. The mitigation was designed from the start, and everything that follows happened regardless.

Biodiversity: the cost of a physical footprint

Environmental controversy across infrastructure concentrates on industrial accidents, water pollution, and biodiversity, and hydropower leads the third, outright, because dams require the permanent conversion of river systems and the land around them. Mexico's Federal Electricity Commission won environmental approval in September 2014 for the Las Cruces dam on the San Pedro Mezquital, upstream of Marismas Nacionales, a Ramsar-protected wetland, even though the project's own impact statement conceded that the damage to Indigenous ceremonial sites could not be mitigated. Along the Mekong River, river health and fish populations fell as dam construction spread through the basin. In Brazil, the Doce River carried a mass release of toxic material after an upstream failure. Elsewhere, the record includes violations of the Endangered Species Act and documented disruption to rainfall patterns.

At Belo Monte, the consequences have been measured rather than projected. The plant diverts water into a canal that bypasses a 130-kilometer stretch of the Xingu known as the Volta Grande, which has received less than 30% of its natural annual discharge since 2019, and some 86% of the stretch's seasonally flooded vegetation, 30,748 of 35,600 hectares, can no longer be inundated at all. The gap lies in the regulator's own file: IBAMA's technical staff called for 10,900 cubic meters per second in February, the historic peak month, compared with the 1,600 that the operating regime actually releases. Seven years of underwater video survey data published in Scientific Reports recorded total fish species richness falling from 62 to a post-operation average of 51, with the steepest losses near the dam and in the rocky rapids, which hold roughly 2.6 times as many species as sandy reaches. The zebra pleco, whose entire known range lies inside the dewatered stretch, now sits on Brazil's national list of threatened species as critically endangered.

None of this is an accident or a failure of operation. It is a structural consequence of the asset. A well-run dam still floods a valley, and a dam engineered specifically not to flood one still dewater the river below it.

When engineering fails: hydropower's physical risk profile

Coal mining leads infrastructure on industrial accidents, where the record is dominated by human tragedy and safety negligence: explosions, collapses, fires, and repeated, incremental failures. Hydropower ranks second, but its accidents take a different form, because in this sector, industrial failure means catastrophic engineering failure at scale. The record includes pipe ruptures causing severe land erosion, oil leaks, and dam collapses that killed and displaced people across whole regions, while PG&E's settlement over damages to the Middle Fork American River Hydroelectric Project and the litigation still running in Brazil after dam collapses give a sense of the exposure a single event can generate. For anyone underwriting these assets, the distinction is financial as much as physical: a coal mine's safety record is a rising cost curve, while a dam's structural integrity is a low-probability, near-unbounded loss.

At Belo Monte, that exposure has so far been financial. The project was budgeted at R$28.9 billion when Brazil's development bank approved a then-record R$22.5 billion loan in November 2012, and by late 2017, actual investment had reached R$38.6 billion, roughly 34% over. The operator owed R$28.3 billion to lenders and debenture holders at the end of 2024. Aliança Norte Energia Participações, the Vale and Cemig vehicle holding a stake in the project, discloses a possible loss of R$3.05 billion from a single construction-delay claim and describes the operator's liquidity as its principal point of attention and a source of investor alert. Neoenergia wrote off its own 10% holding by R$482 million in the fourth quarter of 2021.

The physical risk has been closer than the absence of a collapse suggests. In October 2019, the operator wrote to the national water regulator declaring an emergency, because reservoir levels had fallen far enough to expose an unprotected section of the Pimental dam's earthfill base to wind-driven wave erosion and, in the company's own words, structural damage. It cut outflow below the level agreed with the environmental regulator to protect the structure, and the letter surfaced only through investigative reporting.

Beyond the environment: displacement, water, and chronic corruption

Right to property

Hydropower ranks first among infrastructure sectors for property disputes, a direct function of the footprint a dam and reservoir require. The record shows land seizures, forced displacement, compensation that arrives short or not at all, communities never consulted before ground was broken, and blasting that cracked the foundations of nearby homes. Those affected are frequently the least equipped to hold an operator to account.

Fifteen years after Belo Monte broke ground there is still no audited count of who lost their homes. Estimates run from 20,000 to 40,000 depending on the definition used, against the operator's account of rehousing some 6,000 urban families. Landowners say expropriations are priced at unadjusted 2013 values while the project's own construction boom inflated the market, and as of 2025 none of the land required for the riverine resettlement program had been bought. A petition filed with the Inter-American Commission in 2011 still has no ruling.

Community health and safety

Hydropower sits alongside coal and nuclear as a leading source of community health disputes, but it arrives by a different route. Coal delivers PM2.5, nuclear delivers radioactive anxiety, and hydropower delivers water mismanagement: overconsumption that strips farmers of a livelihood, contaminated water reaching local crops. The grievance is agricultural rather than industrial, which widens the affected population considerably.

On the Volta Grande, catch per fisher fell from 11.1 kilograms a day between 2001 and 2008 to 4.53 kilograms between 2020 and 2023. A randomized household survey found 38.5% of residents in Belo Monte's resettlement neighborhoods living with moderate or severe food insecurity, against 28.3% across the surrounding city. In June 2026, federal prosecutors sought as interim relief for 635 families along the reduced-flow stretch the emergency delivery of three and a half to five liters of drinking water per person per day.

Corruption and bribery

Corruption and bribery accounts for close to 30% of governance controversy across infrastructure. What separates hydropower is the pattern. In airports, nuclear, and coal, corruption surfaces as discrete scandals: a probe opens, executives are charged, attention fades. In hydropower it keeps returning, tied repeatedly to falsified records and payments to local officials to secure land and water rights. Isolated scandals point to isolated actors. A pattern that recurs points to how these projects get permitted.

Brazilian prosecutors alleged that Belo Monte's construction contracts carried bribes worth 1% of their value, and three contractors admitted cartel conduct and kickbacks under leniency agreements that carried immunity. Everything after that was procedural closure rather than a finding of liability: the principal defendants were acquitted and the acquittal upheld on appeal in 2024, the competition authority archived its bid-rigging case in 2025, and no individual has been convicted in connection with the project. An investor screening for enforcement outcomes would have found a closed file. The costs landed elsewhere, in permitting delay, financing conditions, and a minority stake that has been for sale since 2022 without a buyer.

Hydropower's risk concentration: what this means

Hydropower's classification as clean energy is accurate on the metric it was designed to measure, because generation is low-carbon. But carbon intensity is one dimension of sustainability, and it is not the dimension that produces operational friction, legal exposure, or the loss of a social license.

What drew sustained opposition to these projects was water rights, displaced communities, cracked foundations, converted wetlands, and permits secured through local payments. None of it appears in a carbon accounting framework.

For investors, insurers, and lenders seeking transition-aligned infrastructure exposure, that is a material blind spot: an asset class that screens well on the primary criterion while carrying the heaviest social burden in the dataset, and carrying it on behalf of people who have no employment relationship with it. Belo Monte was engineered to avoid precisely that outcome and produced it regardless, which suggests the exposure is not a function of how a dam is built but of what a dam is.

The label is not wrong. It is simply measuring something other than risk.

Read More

In theory, a portfolio with no ESG controversies signals low risk. In practice, experienced analysts treat it as a warning sign. The absence of alerts often reflects not resilience, but limited coverage, fragmented data, or incomplete aggregation. What looks like reassurance may instead point to a gap in visibility.

This dynamic came up repeatedly during our recent webinar, Private Markets in 2026: Macro Trends, ESG Shifts, AI Innovation and What It Means for Deal-Flow. The discussion highlighted how gaps in coverage and aggregation can shape investor perception, particularly when portfolios appear “quiet,” not because risks are absent, but because relevant information is not being captured.

This dynamic matters more than ever as private market due diligence intensifies. With fewer deals, longer holding periods, and higher selectivity, investors are spending more time scrutinizing assets before acquisition and monitoring them for longer after entry. Yet the informational foundation behind many ESG assessments has not caught up with these expectations.

“Most of our clients in private equity or banking would come to us because they haven’t found a solution that properly covers their portfolio of assets. And so when nothing happened on that portfolio, that was not perceived as a positive thing.” Sylvain Forté.

When "No Data" Becomes "No Risk"

Private assets operate under persistent disclosure constraints. Unlike public companies, most private firms do not produce standardized, recurring ESG disclosures, nor do they benefit from consistent analyst coverage. These gaps are structural and unlikely to disappear in the near term.

In this context, silence is ambiguous. A clean ESG screen may indicate the absence of material issues, but it may just as easily signal that no relevant information was captured. Language limitations, fragmented sources, and uneven coverage across geographies and asset types all contribute to this uncertainty.

This dynamic is particularly visible in secondary transactions. Deal teams often need to assess large portfolios under tight time pressure, with limited access to management and incomplete identifiers. In such cases, relying on the absence of signals can create false confidence rather than reduce risk.

How Weak Coverage and Duplicated Signals Create Blind Spots

Even when information exists, it is not always immediately actionable. Adverse media has become a valuable substitute where structured ESG data is limited, offering outside-in visibility into private assets. However, it is not without challenges. Without robust aggregation and cross-language consolidation, the same issue can appear repeatedly across multiple articles, jurisdictions, and languages, creating duplication rather than clarity. At the same time, gaps in coverage or weak filtering can allow other material risks to go undetected.

At the same time, some portfolios appear unusually quiet simply because the underlying assets fall outside the scope of traditional datasets. ESG and reputational expectations in private markets remain fragmented, with bespoke workflows driven by LP-specific requirements. This lack of convergence makes it difficult to distinguish between genuinely low exposure and analytical gaps.

More data does not automatically resolve this problem. Without traceability, source quality, and a way to assess financial, legal, or operational materiality, increased volume can add noise without improving decisions. In that environment, silence can be just as misleading as signal overload.

What Meaningful ESG Visibility Looks Like Under Disclosure Constraints

A core takeaway from the webinar was that point-in-time ESG assessments are no longer fit for purpose in private markets. A single diligence exercise conducted at entry cannot capture emerging governance failures, litigation, reputational issues, or supply chain risks over multi-year holding periods.

Instead, meaningful ESG visibility combines three elements:

  • Broad coverage, to avoid portfolios appearing "low risk" simply because assets are not captured.
  • Aggregation and severity assessment, to separate isolated news from controversies with real financial or operational implications.
  • Continuous monitoring, so the original risk thesis evolves as new information emerges rather than remaining static.

This approach reframes ESG from a compliance exercise into a source of informational advantage. Rather than concluding that no alerts mean no risk, investors use ESG signals to guide follow-up questions, prioritize deeper diligence, and identify issues that were not visible at entry.

Replacing False Comfort with Informed Uncertainty

Private markets will continue to operate with imperfect information. Disclosure gaps, opaque supply chains, and bespoke reporting demands are inherent to the asset class.

Treating “no issues detected” as a conclusion creates false comfort. Treating it as a hypothesis, contingent on coverage quality and monitoring depth, aligns ESG analysis with how risk actually emerges in private assets.

SESAMm’s AI Technology Reveals ESG Insights

Discover unparalleled insights into ESG controversies, risks, and opportunities across industries. Learn more about how SESAMm can help you analyze millions of private and public companies using AI-powered text analysis tools.

ESG Assessment: Eureden

February 18, 2026
5 mins read

Eureden is a large farmer‑owned French agri‑food co‑operative headquartered in Brittany, combining upstream agricultural inputs and advice with downstream vegetables, eggs, meat/charcuterie, dairy, retail chains and labs across roughly 40 industrial sites in France, Germany, Spain and Hungary and generating about €3.7–3.8bn in annual revenue, according to its website and latest integrated report.

Eureden’s main ESG risks stem from legacy health‑and‑safety failings at Triskalia/Nutréa pesticide and feed sites, where French courts repeatedly recognised work accidents and occupational diseases as due to the employer’s “inexcusable fault” in pesticide‑exposure cases, including a worker suicide linked to workplace conditions, alongside other labour tensions, recurring though mostly precautionary food and allergen recalls, an environmental enforcement order against an ICPE site, and structural exposure to climate, biodiversity, animal‑welfare and chemical‑use risks from intensive livestock, pesticides and Seveso‑classified storage. At the same time, the company reports a relatively advanced CSR framework, high levels of external certifications (100% of industrial sites under at least one food‑safety/quality standard), externally assured integrated reporting with group‑wide ESG KPIs, CSR‑linked financing and programmes on pesticide reduction, non‑deforestation soy, climate, water and waste, while stating alignment with UN Global Compact principles without being a listed signatory; no international sanctions listings or OECD complaints involving Eureden were identified in public sources.

2026-01-28_2053_esg_ai_screening_report_Eureden.pdf

Reach out to SESAMm

SESAMm's web data analysis of over five million public and private companies is essential for keeping tabs on ESG investment risks. To learn more about how you can analyze web data or to request a demo, reach out to one of our representatives.

BNP Paribas has passed a significant milestone in its energy financing strategy, with more than 80% of its energy production financing now directed toward low-carbon energies.

The increase marks a notable acceleration compared with previous periods. Low-carbon energy financing accounted for approximately 65% of BNP Paribas’ energy production exposure in 2023, rising to around 76% in 2024, before surpassing the 80% threshold in 2025. The category includes renewable energy sources such as wind, solar and hydropower, as well as nuclear energy, which the bank classifies as low-carbon.

At the same time, BNP Paribas has continued to reduce its exposure to fossil fuel energy production. Credit exposure linked to oil and gas projects has declined as financing volumes for renewables and other low-carbon technologies increased, reflecting the bank’s longer-term commitment to rebalancing its energy portfolio in line with climate objectives.
Beyond energy production financing, the bank has also reported progress against its broader transition finance ambitions. By the end of 2025, BNP Paribas had mobilized more than €250 billion in financing supporting the low-carbon transition, exceeding its initial €200 billion target ahead of schedule. The bank has since confirmed updated objectives, including a target to reach 90% low-carbon energy financing by 2030.

While the figures relate specifically to energy production financing exposure, rather than BNP Paribas’ total lending activity, they nonetheless highlight the pace at which large financial institutions are reshaping their energy strategies. As regulatory scrutiny, investor expectations, and transition risks continue to intensify, the composition of energy financing portfolios is increasingly viewed as a key indicator of alignment with long-term climate goals.

Controversial business involvement screening is moving beyond its origins as a compliance exercise.

Under frameworks like SFDR and the EU Taxonomy, investors must prove that their portfolios not only promote sustainability but also exclude activities fundamentally at odds with environmental, social, or ethical principles. This marks a shift from static disclosure toward dynamic accountability, and it has broadened both the scope and ambition of ESG screening.

Historically, exclusions focused on a narrow range of activities - weapons, tobacco, or fossil fuels - and primarily applied to public equities. Today, that universe has expanded dramatically. Private markets, secondaries portfolios, and private credit exposures are now expected to undergo the same scrutiny as listed assets. This reflects not only regulatory alignment but also diversifying investor expectations, as institutions incorporate reputational, cultural, and mission-based constraints into their investment frameworks.

Modern exclusion policies increasingly include areas not yet covered by regulation but relevant to ethics, faith, or social impact. Examples range from pork-related activities in Sharia-compliant portfolios to emerging debates over cryptocurrency mining and trading, and even biotechnology topics such as human cloning or genetic manipulation that raise profound ethical questions. These additions illustrate how business involvement screening is evolving from a rule-based checklist into a reflection of each investor’s worldview and stakeholder commitments.

This evolution, however, brings complexity. Private assets and novel sectors often lack standardized data or public disclosures. ESG, compliance, and deal teams must process incomplete information, document decisions, and adapt quickly to new mandates - all without expanding headcount. The result is a growing need for automation that can adapt to human nuance.

SESAMm’s AI-powered business involvement screening meets that need. By allowing investors to screen based on their own exclusion categories and thresholds, it translates varied mandates - from regulatory to reputational - into a single, automated process.

Automating Controversial Business Involvement Screening in Public and Private Assets

SESAMm’s platform uses a new AI agent approach that scans and analyzes vast amounts of information. Below, we provide an overview of SESAMm’s business involvement screening capabilities and how they address investors’ needs for automation, thresholding, and flexible outputs.

Comprehensive Coverage through Big Data

SESAMm utilizes its AI engine to monitor over 30 billion articles and 10 million new documents daily from various sources, including news sites and NGOs. This extensive data collection spans multiple languages and local outlets, enabling it to detect obscure references to companies and raise alerts for issues such as misconduct. SESAMm's coverage encompasses millions of public and private companies, enabling users to conduct thorough screenings of any entity, including private companies and subsidiaries.

Customizable Exclusion Frameworks

SESAMm’s business involvement screening gives investors control over what to screen and how to classify it. Users can request customization of exclusion categories to mirror their own policy, whether based on regulation (e.g., SFDR, EU Taxonomy) or internal mandates (e.g., faith-based or reputational constraints). In addition to standard ESG categories like fossil fuels or weapons, investors can add custom topics. This flexibility allows ESG, compliance, and secondaries teams to tailor the tool to their precise needs,.

Threshold-Based Classification

SESAMm’s business involvement screening module is built around the concept of threshold-based flags. The AI utilizes structured data and unstructured signals to determine involvement levels. The output for each company is a clear classification: No Involvement, Limited Involvement, or Significant Involvement for each category. These classifications correspond to thresholds – limited might mean some involvement but below the exclusion threshold, significant means above the threshold or its a core business. By encoding the thresholds in the system, SESAMm ensures consistency with the investor’s policy. This is crucial for automation: rather than an analyst manually checking revenue percentages and news, the system does it automatically and provides clear justification.

Rapid Portfolio Screening Process

The system is designed for fast, self-contained screening. A user simply uploads a list or portfolio, and within hours receives a complete file summarizing involvement across all exclusion categories. The output includes company-level classifications, summaries of supporting evidence, and references to sources. This enables investors to integrate the results directly into due diligence workflows, risk committees, or regulatory reporting, with no ongoing manual data maintenance required.

Cost and Resource Efficiency

Automating this process saves substantial analyst time, particularly for rating agencies and secondaries investors managing high volumes of entities. Rating agencies can use the pre-classified results as a baseline input for their own ESG or credit assessments, reducing the manual data-gathering burden. LPs and GPs can run large private company universes in-house without additional research teams. In secondaries, where a full portfolio review can take days of analyst effort, SESAMm’s workflow compresses that timeline to just a few hours, enabling ESG validation to fit seamlessly into transaction schedules.

Auditability and Verification

Each classification is fully transparent. Analysts can drill down into the evidence behind a flag, including links to original articles, filings, or corporate statements, and verify the AI’s reasoning. Automatic translation ensures accessibility across languages. This transparency builds trust in the results and provides auditable documentation for LP reporting or regulator reviews.

As ESG investing matures, the leaders will be those who can implement exclusions transparently, efficiently, and in alignment with evolving norms. The next frontier is no longer just regulatory compliance - it is the ability to anticipate what clients and society will expect tomorrow, and to operationalize those expectations across all asset classes. SESAMm’s technology makes that possible: a platform that keeps pace with both policy evolution and moral expectations, bringing consistency and clarity to an increasingly complex ESG landscape.

Screening a portfolio for controversial business involvement is fundamentally different in public markets than in private markets. Public assets benefit from established disclosure requirements, third-party coverage, and standardized data, while private assets operate in a far more opaque environment. For ESG teams at LPs and GPs, these differences become especially acute in secondaries transactions, where investors inherit portfolios they did not originate and must assess risk under tight timeframes.

As regulatory frameworks such as SFDR extend similar expectations to private market funds, the gap between public and private screening becomes harder to ignore. Investors are increasingly expected to apply consistent exclusion policies and demonstrate rigorous screening across asset classes, even when data availability, transparency, and control differ materially.

This article examines the practical challenges of screening secondaries portfolios across public and private markets. It highlights where traditional approaches fall short, explores the structural constraints faced by LPs and GPs, and illustrates how hidden exposure can persist in private assets through the case of Crown Resorts and its governance and gambling-related controversies.

Data Availability and Transparency

Public companies typically provide more data through annual reports, revenue disclosures, and ESG rating coverage. For example, a company like Philip Morris International openly reports that almost 100% of its revenue comes from tobacco, making exclusion straightforward. That said, public market screening still relies heavily on self-reported information, which has its own limitations.

Private companies, by contrast, often disclose little to nothing about their business mix. A mid-market private firm may provide no public indication of its activities at all. As a result, GPs have traditionally relied on questionnaires, web searches, and due diligence calls to identify “sin” activities, a manual and imperfect process. Because private companies have no obligation to report controversial involvement, issues may surface only after investment. This opacity places pressure on GPs to demonstrate robust screening, particularly for SFDR Article 8 and 9 funds expected to apply comparable rigor to private assets without comparable data.

Coverage by Third-Party ESG Providers

Public markets benefit from broad coverage by ESG data and controversy research providers that maintain structured involvement lists across sectors such as weapons or gambling. Private markets face a clear coverage gap. LPs cannot assume that external ratings or datasets will flag problematic private companies.

This gap is particularly material for activities more prevalent in private markets, such as predatory lending or adult content platforms,  which are rarely publicly listed. Traditional ESG datasets may miss these exposures entirely. Without alternative data sources, an Article 8 private debt fund could unknowingly finance a highly controversial company simply because it does not appear on any public exclusion list.

LP/GP Constraints and Mandates

Many LPs maintain their own exclusion policies and expect GPs to apply them consistently. In public markets, asset owners can screen holdings directly. Whereas, in private markets, LPs must rely on GPs to implement exclusions during sourcing and due diligence.

This reliance creates friction. A financially attractive deal may still be incompatible with LP mandates, forcing GPs to walk away. Under SFDR, GPs marketing Article 8 or 9 funds must demonstrate that portfolio companies align with promoted ESG characteristics, including exclusions for sectors such as weapons or tobacco. LP due diligence questionnaires increasingly reflect this scrutiny.

Secondaries investors face additional pressure. They must assess large portfolios they did not originate, often under tight timelines. Hidden exposure, such as sanctioned entities or controversial manufacturers, can pose a significant risk, driving increased use of accelerated ESG screening tools prior to acquisition.

Dynamic vs. Static Nature of Private Investments

Public market portfolios can be adjusted quickly if a controversy emerges. In private markets, investors are typically locked in for years, making pre-investment screening far more critical. A failure to identify controversial involvement can leave GPs choosing between remediation efforts and reputational damage.

Private companies also evolve with limited visibility. A business may pivot into controversial activities without public disclosure, and such shifts may only be detectable through external reporting rather than formal announcements. This reinforces the need for both rigorous upfront screening and ongoing monitoring throughout the holding period.

Case Study: Crown Resorts - Gambling and Governance Failures

Company Overview

Crown Resorts is Australia’s largest casino operator, running flagship properties in Melbourne, Perth, and Sydney. Its business model centers entirely on gambling & betting, making it a textbook case of significant involvement - essentially 100% exposure to an exclusion category that many funds ban or cap at ≤5–10% of revenue. Following a string of governance scandals, Crown was acquired by Blackstone in 2022 and delisted, offering a strong private-market example of why business involvement screening must extend beyond public companies.

Controversies SESAMm’s AI screening captures a sequence of serious ESG and regulatory failures:

  • International illegality: 2016 arrests of 18 employees in China for promoting gambling in violation of Chinese law.
  • Money laundering & crime links: laundering through casino accounts and continued partnerships with junket operators later tied to organized crime.
  • Regulatory sanctions: inquiries in New South Wales, Victoria, and Western Australia declared Crown “unsuitable” to hold licenses; regulators imposed monitoring and fines totaling A$200 million+.
  • Predatory behavior: evidence of loan-sharking within casino premises, and failure to protect patrons from exploitation.

Screening Outcome

Crown is classified as significant involvement in Gambling & Betting, with additional flags under Sanctions & Exclusions. It also shows limited exposure to predatory Lending and minor environmental issues.

Screening Takeaway

Crown demonstrates how a company’s core business model (gambling) can intersect with multi-dimensional ESG risks (AML, governance, and social harm). In private markets, where disclosures are minimal, AI-driven screening enables investors to detect red flags early, determine whether engagement or exclusion is appropriate, and avoid inheriting reputational or regulatory liabilities.

SESAMm’s AI Technology Reveals ESG Insights

Discover unparalleled insights into ESG controversies, risks, and opportunities across industries. Learn more about how SESAMm can help you analyze millions of private and public companies using AI-powered text analysis tools.

There’s no denying that ESG risk exposure in the pharmaceutical industry is high. This stems from the intense regulatory oversight, complex global operations, and the sector’s direct impact on public health. Governance issues represent the most persistent challenge, with leading companies repeatedly facing bribery and corruption cases, antitrust and excessive pricing investigations, misleading marketing practices, patent disputes, and data integrity concerns, often resulting in significant fines, large settlements, and prolonged legal scrutiny across jurisdictions.

Social risks are closely tied to product safety and workforce management, as evidenced by recurring drug recalls, regulatory suspensions, and litigations linked to adverse patient outcomes, alongside layoffs, labor disputes, and workplace safety concerns. Environmental risks, while comparatively less frequent, increasingly center on credibility and compliance, including sustainability reporting weaknesses, greenwashing allegations, and operational environmental violations.

What are the most persistent ESG challenges in the pharmaceutical industry? Read on to find out.

GlaxoSmithKline: Legal Battles and Social Accountability

While taking a deeper look at GlaxoSmithKline (GSK), we found that the company has a very high Controversy Exposure Score (CES) of 88/100. This elevated score reflects a sustained pattern of governance and social controversies rather than isolated incidents.
On the governance side, GSK has repeatedly faced major legal and regulatory actions, including a $2.2 billion settlement linked to Zantac, a $235 million patent award upheld by the U.S. Supreme Court, and multiple fines for misleading marketing, anticompetitive behavior, and bribery. Several of these events are flagged as UN Global Compact (UNGC) violations, particularly under principles related to anti-corruption, labor rights, and ethical business conduct, while others remain under UNGC watchlist classification.

Social risks further expose GSK, including recurring product recalls and regulatory suspensions tied to contamination, dosing, and packaging defects, as well as labor disputes, strikes, and large-scale layoffs across Europe and the United States. Together, the CES score and UNGC screening highlight persistent governance weaknesses and social risk drivers that continue to shape GSK’s overall risk profile.

gsk

Key Controversies:

Novartis: Governance and Sustainability Concerns

Similar to GSK, Novartis shows very high controversy exposure, with a CES of 84/100, reflecting sustained ESG headwinds rather than isolated events. Governance risks are the primary driver of this elevated score, with Novartis facing repeated fraud and bribery allegations, competition and price-fixing investigations, patent disputes, and data integrity concerns across multiple jurisdictions. These issues have resulted in significant financial consequences, including nearly $1 billion in U.S. settlements related to improper physician incentives, $345 million to resolve foreign corruption cases, a €444 million antitrust fine in Europe, and several high-value patent dispute settlements.

A number of these controversies are flagged under UNGC screening, primarily classified as Watchlist events, particularly in relation to anti-corruption, ethical conduct, and legal compliance. Environmental risks also contribute to Novartis’ exposure, following greenwashing allegations and scrutiny over the credibility of its net-zero commitments. On the social front, large-scale workforce reductions, protests, strikes, and voluntary product recalls linked to safety oversight have further intensified the company’s overall risk profile.

novartis

Key Controversies:

Roche: Facing the Spotlight on Governance and Ethics

While lower than some of its peers, Roche shows a high level of controversy exposure, with a CES of 64/100. This score still reflects recurring ESG controversies across governance, social, and operational dimensions. Governance-related risks are the main contributors, with Roche involved in multiple lawsuits linked to bribery allegations, antitrust and excessive pricing practices, patent disputes, and marketing misconduct, including a €444 million antitrust fine in Europe.

Several of these events are captured under the UNGC screening, predominantly classified as Watchlist cases, particularly in relation to anti-corruption, competition practices, and governance standards. Environmental risks have also emerged, with the Ethos Foundation publicly challenging Roche’s sustainability reporting and executive remuneration practices, and its subsidiary Genentech was fined $158k for hazardous materials violations. On the social front, Roche has faced drug recalls tied to safety deficiencies, large-scale global layoffs, reported employee exposure to hazardous substances, and legal rulings related to workplace discrimination, all contributing to its overall ESG risk profile.

roche holding

Key Controversies:

Conclusion

Across GlaxoSmithKline, Novartis, and Roche, ESG risk in the pharmaceutical sector is clearly structural. Governance controversies remain the most persistent and financially material, while social risks tied to product safety and workforce practices continue to drive litigation and reputational pressure. Environmental issues, though less frequent, increasingly raise questions around credibility and compliance.

Together, these cases highlight the need for continuous, forward-looking risk monitoring in a sector where regulatory scrutiny, public trust, and long-term value are tightly connected.

Reach out to SESAMm

TextReveal’s web data analysis of over five million public and private companies is essential for keeping tabs on ESG investment risks. To learn more about how you can analyze web data or to request a demo, reach out to one of our representatives.

ESG | AI

A Clearer View of Risk: A New Year's Message from SESAMm

January 21, 2026
5 mins read

As 2026 kicks off, I want to take a moment to reflect on the year we’ve just closed. 2025 was an important year for SESAMm, marked by both significant milestones and quieter, foundational progress. We launched new AI-powered reports, welcomed major clients, expanded our coverage, and saw our technology move deeper into real decision-making workflows.

None of this would have been possible without the trust and engagement of our clients, partners, advisors, and team. Your willingness to challenge us, work with us, and build alongside us continues to shape what SESAMm becomes.

Below, I’ve shared a few moments from 2025 that helped move us forward, along with what we’re looking ahead to in 2026.

Growing Through Strong Partnerships

In practice, SESAMm’s data is used in very different ways. It supports large-scale monitoring across thousands of suppliers and assets, while also enabling in-depth analysis of individual companies and local markets.

In 2025, collaborations with organizations such as Sayari, BNP Paribas, Caisse d’Epargne Rhône Alpes, ENGIE, Clarity AI, and Inrate reinforced something we have believed from the beginning: understanding risk today requires data that is both scalable and usable within real decision-making workflows.

More importantly, these partnerships reflect the confidence placed in the quality of SESAMm’s data and its breadth of use. In one case, a financial institution used supplier monitoring to identify early signals of forced labor risk in a supply chain that had previously passed traditional audits. That insight did not replace existing processes, but it changed the questions being asked and the actions that followed.

Welcoming New Advisors

We were also proud to welcome Guy Gresham and Magnus Billing as advisors this year. Their experience, perspective, and intellectual rigor have already challenged us in the best possible way.

As we continue to build SESAMm for the long term, their guidance helps ensure that our technology remains both ambitious and grounded in how risk is actually understood, assessed, and managed in the real world. In a market that is evolving quickly and sometimes unpredictably, that discipline matters.

From AI Promises to AI in Practice

AI dominated conversations again this year. What changed in 2025 was less the technology itself, and more how our clients engage with it.

Initially, the question was whether AI could reliably identify risks. Today, that question has been answered and the conversation has shifted. Clients are asking which risks are most important, which require action, and how to prioritize limited time and resources.

At SESAMm, this translated into concrete product evolution, all with the same objective: supporting both large-scale monitoring and deeper, decision-level analysis. We launched and expanded AI-powered reports, introduced UN Global Compact violation screenings, and significantly increased the number of companies and infrastructure projects we cover globally.

AI is no longer treated as an experimental layer. Our clients are using it as a core component for identifying and tracking risks over time. The question they now face is not whether AI can surface risk, but how to decide which signals deserve attention.

ESG Is Changing, Whether We Like the Term or Not

AI The ESG landscape itself is going through a transformation. Regulatory pressure is uneven. In some regions, expectations are tightening while in others, frameworks are being diluted or politicized. At the same time, the term “ESG” is itself losing ground; it means too much and therefore explains too little.

That has not changed, however, is the nature of the underlying risks. Human rights, forced labor, biodiversity loss, governance failures, and reputational exposure are becoming increasingly visible and material to investors, companies, and regulators alike. The conversation is shifting from broad labels to specific facts, with greater attention paid to the events and the evidence that inform both scores and decisions. This shift from labels to evidence is where SESAMm’s approach is particularly relevant.

Looking Forward

As we move further into 2026, our focus remains clear. We will continue to invest in signal quality over noise, depth over surface-level insight, and tools that help our clients act, not just observe. We will keep expanding coverage where risk is hardest to see, particularly in private markets, and will continue to develop cutting-edge AI agents to support client workflows.

The question for 2026 is not simply how much risk data organizations have, but how effectively they interpret and prioritize it in practice.

Above all, we remain committed to building technology that supports our customers and partners with clear, reliable insight into risk, grounded in reality as it is.

Thank you again to our clients, partners, advisors, and team for your trust and engagement over the past year. We look forward to continuing this journey together!

Wishing you a wonderful and successful year ahead,

Sylvain Forté
CEO, SESAMm

Reach out to SESAMm

TextReveal’s web data analysis of over five million public and private companies is essential for keeping tabs on ESG investment risks. To learn more about how you can analyze web data or to request a demo, reach out to one of our representatives.

The Sustainable Finance Disclosure Regulation (SFDR) is the EU’s framework for governing how sustainability considerations are disclosed in investment products. While designed to improve transparency and reduce greenwashing, SFDR gradually evolved into a de facto labelling system, with Articles 8 and 9 shaping how funds were marketed and perceived.

In late 2025, the European Commission put together an SFDR 2.0 proposal. It’s intended to acknowledge that this approach has created complexity, inconsistency, and confusion for investors. By shifting toward clearer product categories and simpler disclosures, the reform aims to restore credibility and usability. 

A New Category-Based Framework

SFDR 2.0 introduces three product categories: Sustainable, Transition, and ESG Basics. While categorization is voluntary, funds choosing a category must meet mandatory criteria for that classification. Each category is tied to a minimum 70% portfolio alignment with the stated strategy, alongside mandatory exclusions for activities such as those involving controversial weapons, tobacco, hard coal, and severe breaches of international norms. Products outside these categories face tighter limits on ESG-related naming and marketing claims.

Sustainable products are reserved for funds investing primarily in sustainable activities or assets, including taxonomy-aligned strategies and Paris-aligned benchmarks. These products are subject to the strictest fossil fuel exclusions, including a ban on new coal, oil, and gas development.

Transition products are designed to capture strategies financing the shift toward sustainability. They rely on credible transition plans, science-based targets, and structured engagement, with tighter restrictions on fossil fuels than ESG Basics products and a clear focus on forward-looking change.

ESG Basics products integrate ESG approaches in the investment strategy but do not qualify as Sustainable or Transition. While still subject to baseline exclusions and the 70% alignment rule, this category has drawn early criticism for its relatively lenient treatment of fossil fuels.

Less Complexity, Tighter Guardrails

SFDR 2.0 removes entity-level PAI disclosures and simplifies product templates. Rather than relying on the current sustainable investment definition and DNSH mechanics in SFDR 1.0, the proposal operationalizes ‘no harm’ and safeguards through a common exclusion baseline plus product-level disclosure of principal adverse impacts, with DNSH and good governance reflected via category criteria.
Disclosures are significantly shortened, with pre-contractual and periodic reports capped at two pages, and marketing rules tightened to limit sustainability claims to qualifying products.

The intent is clear. SFDR 2.0 shifts from dense, technical disclosures toward clearer categories supported by exclusions and simpler safeguards.

Timeline and Market Impact

The legislative process is expected to conclude in late 2026 or early 2027, followed by an 18-month implementation period. Until then, asset managers must continue complying with SFDR 1.0 while preparing for a full reclassification of their product ranges.

For the market, this likely means a smaller but more clearly defined universe of labelled funds. Many current Article 8 and 9 products are expected to reclassify, while Sustainable products under the new regime may be fewer but broader in scope. Asset managers face near-term transition costs and communication challenges, but also the prospect of greater long-term clarity and reduced compliance complexity.

A Reform Still Under Scrutiny

Initial reactions have been mixed. Industry groups broadly welcome the simplification and stronger fossil fuel exclusions for Sustainable and Transition products. At the same time, concerns persist regarding the scope of the ESG Basics category, the lack of a level playing field for unclassified funds, and the absence of more stringent engagement requirements for transition strategies.
Organizations such as Eurosif and Morningstar have described the proposal as a step forward that still leaves room for improvement, particularly in preventing greenwashing at the lower end of the spectrum. Triodos Investment Management has also voiced similar caution.

What SFDR 2.0 Signals

SFDR 2.0 reflects a broader recalibration in EU sustainable finance policy. After years of expanding disclosure requirements, the focus is shifting toward usability, clarity, and enforceable standards. For asset managers, the message is straightforward: Sustainability claims will be more tightly defined, product positioning will matter more, and the margin for ambiguity is narrowing as SFDR enters its next phase.

The biotech industry faces significant ESG risks, particularly in governance. Social and operational risks are less common but still material.

Across the sector, companies like Cassava Sciences, BrainStorm Cell Therapeutics, and Anavex Life Sciences frequently face governance controversies, including shareholder and class action litigation, security fraud, SEC investigations, and more. While social risks are generally secondary, they are notable in areas such as workforce reductions, layoffs following acquisitions, and labor disputes, with patient-safety considerations emerging in therapies with adverse effects.

What are the most pressing ESG challenges currently facing the biotech sector? Read on to find out.

Cassava Sciences: Governance and Transparency Concerns

Cassava Sciences has a high Controversy Exposure Score, the result of its involvement in several severe ESG controversies. The company has faced class action and shareholder litigation, resulting in settlements of $31M and $40M over allegedly misleading statements related to its Alzheimer’s drug, Simufilam. Governance concerns are further amplified by allegations of manipulating trial data and scientific misconduct, which have attracted both SEC investigations and reports of criminal probes. Additional legal controversies include malicious prosecution and defamation lawsuits filed in response to alleged “short and distort” campaigns. On the social side, Cassava has faced a 33% reduction in its workforce, reflecting operational restructuring.

Key Controversies:

Anavex Life Sciences: Lawsuits and Regulatory Scrutiny

Anavex Life Sciences faces notable governance risks, primarily stemming from shareholder litigation and concerns regarding the integrity of its clinical trials. Multiple class action lawsuits allege misrepresentation and deceptive practices, particularly in reporting outcomes for Rett syndrome and Alzheimer’s disease trials. Governance concerns are compounded by data inconsistencies, changes in trial evaluation criteria, and regulatory scrutiny, including the EU’s rejection of its Alzheimer’s drug.

Key Controversies:

BrainStorm Cell Therapeutics: Fraud and Credibility Allegations

BrainStorm Cell Therapeutics exhibits a concentrated governance risk profile, with issues spanning several aspects. Class action lawsuits and securities fraud claims allege investor harm from misstatements, while the company faces lawsuits for overstating FDA feedback and misrepresenting the efficacy of its ALS therapy, NurOwn. These allegations are reinforced by FDA panel and reviewer concerns, raising questions about its scientific credibility. BrainStorm is also facing delisting from Nasdaq and a breach of contract lawsuit. On the social front, the company’s ESG exposure stems from plant shutdowns, workforce restructuring, and job cuts, raising labor practice concerns.

Key Controversies:

Conclusion

The biotech industry’s ESG profile is increasingly shaped by governance-related controversies, particularly around transparency, litigation, and regulatory scrutiny. Companies like Cassava Sciences exemplify how unresolved allegations, ranging from trial data manipulation to securities fraud, can significantly shake stakeholder trust and financial stability. While social and operational risks appear less frequently, workforce reductions, safety concerns, and labor disputes highlight broader vulnerabilities tied to the sector’s rapid pace and scientific complexity. As the industry continues to innovate, managing these ESG risks will be crucial not only for compliance but also for long-term credibility and sustainable growth.

Reach out to SESAMm

TextReveal’s web data analysis of over five million public and private companies is essential for keeping tabs on ESG investment risks. To learn more about how you can analyze web data or to request a demo, reach out to one of our representatives.

Stay ahead with the latest in ESG and AI intelligence

Join our mailing list to receive new reports, event invites, and updates from SESAMm directly to your inbox.